Insulin analogs and pregnancy: an update
- 16 June 2009
- journal article
- review article
- Published by Springer Nature in Acta Diabetologica
- Vol. 46 (3) , 163-172
Abstract
It is well known that good metabolic control maintained throughout pregnancy reduces maternal and fetal complications in diabetes. Before conception and throughout pregnancy, insulin therapy needs to be optimized and, in this context, the insulin analogs currently available in the market may help to achieve good metabolic control. We therefore review here what is known about the potential benefits and risks related to the use of these new insulins in pregnancy. Clinical and experimental data on insulin aspart and lispro strongly suggest that they have no adverse maternal or fetal effects during pregnancy in women with pregestational and gestational diabetes, and that their use results in improved glycemic control, fewer hypoglycemic episodes, and improved patient satisfaction. At present there are no published data on the use of glulisine in pregnancy. Insulin glargine during pregnancy is not recommended but, in the last years, larger surveys (retrospective and case–control studies) have been published on this field and, to date, results of about 335 pregnancies with type 1 diabetes are available showing an incidence of congenital malformation similar to that obtained with human insulin. There are no published data concerning the use of detemir in pregnancy but the results of a prospective study are expected in 2010.Keywords
This publication has 76 references indexed in Scilit:
- Standards, guidelines and the practice of medicineActa Diabetologica, 2008
- The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetesActa Diabetologica, 2008
- Perinatal outcomes associated with the use of glargine during pregnancyDiabetic Medicine, 2008
- Italian standards for diabetes mellitus 2007: executive summaryActa Diabetologica, 2008
- Insulin, insulin analogues and diabetic retinopathyArchives of Physiology and Biochemistry, 2008
- Efficacy, safety and lack of immunogenicity of insulin aspart compared with regular human insulin for women with gestational diabetes mellitusDiabetic Medicine, 2007
- Goals of Metabolic Management of Gestational DiabetesDiabetes Care, 2007
- Pharmacokinetics and Pharmacodynamics of the Long-Acting Insulin Analog Glargine After 1 Week of Use Compared With Its First Administration in Subjects With Type 1 DiabetesDiabetes Care, 2007
- Use of insulin glargine during pregnancy: a case-control pilot studyBJOG: An International Journal of Obstetrics & Gynaecology, 2007
- Does insulin detemir have a role in reducing risk of insulin‐associated weight gain?Diabetes, Obesity and Metabolism, 2006